Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study

Abdel-Rahman Omar

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study

【24h】

Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study

机译：基线特征对索拉非尼治疗的晚期HCC患者的结果：III期研究的二级分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background The current study aims to investigate the impact of baseline characteristics on the outcomes of sorafenib-treated advanced Hepatocellular carcinoma (HCC) patients in the setting of a clinical trial.

机译：背景目前的研究旨在调查基线特征对索拉非尼治疗晚期肝细胞癌（HCC）患者临床试验结果的影响。

著录项

来源
《Journal of Cancer Research and Clinical Oncology》 |2018年第5期|共8页
作者
Abdel-Rahman Omar;
展开▼
作者单位

Ain Shams Univ Dept Clin Oncol Fac Med Cairo Egypt;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Sorafenib; HCC; BMI; ALBI; Prognosis;

机译：Sorafenib;HCC;BMI;ALBI;预后;

相似文献

外文文献
中文文献
专利

1. Phase Ⅰ dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unresectable locally advanced or metastatic gastric cancer [J] . Yihebali Chi, Jianliang Yang, Sheng Yang, 中国癌症研究（英文版） . 2015,第003期
2. Value of Kidney Disease Improving Global Outcomes Urine Output Criteria in Critically Ⅲ Patients: A Secondary Analysis of a Multicenter Prospective Cohort Study [J] . Jun-Ping Qin, Xiang-You Yu, Chuan-Yun Qian, 中华医学杂志（英文版） . 2016,第017期
3. Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study [J] . Abdel-Rahman Omar Journal of Cancer Research and Clinical Oncology . 2018,第5期

机译：基线特征对索拉非尼治疗的晚期HCC患者的结果：III期研究的二级分析
4. 6621 Effect of macroscopic vascular invasion (MVI), extrahepatic spread (EHS), and ECOG performance status (ECOG PS) on outcome in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib: analysis of two phase III, randomized, double-blind trials [J] . J.Raoul, A.L.Cheng, Y.K.Kang, European Journal of Cancer Supplements . 2009,第2期

机译：6621索拉非尼治疗的晚期肝细胞癌（HCC）患者的宏观血管侵犯（MVI），肝外扩散（EHS）和ECOG表现状态（ECOG PS）的效果：两个III期，随机，双盲分析试验
5. Impact of baseline characteristics on extensive‐stage SCLC patients treated with etoposide/carboplatin: A secondary analysis of a phase III study [J] . Abdel‐Rahman Omar The clinical respiratory journal. . 2018,第10期

机译：基线特征对依托磷脂/卡铂治疗的广泛阶段SCLC患者的影响：III期研究的二级分析
6. Impact of Renal Insufficiency on 30-Day Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention [C] . Sakai K., Tosaka A., Soga Y., World Congress on Heart Disease. . 2013

机译：肾功能不全对患有初步经皮冠状动脉介入治疗的ST段抬高心肌梗死30天后的影响
7. A longitudinal study of fetal tissue transplantation surgery for the treatment of Parkinson's disease: Can quality of life and optimism at baseline predict patient outcome 10 years later? [D] . Fazio, Emily B. 2011

机译：胎儿组织移植手术治疗帕金森氏病的纵向研究：基线时的生活质量和乐观情绪能否预测10年后的患者预后？
8. Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience [O] . Giulia Rovesti, Giulia Orsi, Andrikou Kalliopi, 2019

机译：基线特征对Sorafenib治疗的HCC患者整体存活的影响：十年经验
9. Corrigendum to ‘Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study’ Eur J Canc 81 (2017) 17–25 [O] . Ian Chau, Markus Peck-Radosavljevic, Christophe Borg, 2018

机译：勘探为索拉芬布一线治疗后患有先进肝细胞癌的患者的二线治疗：随机阶段III REACH研究的患者聚集的结果，从ACCOLIZE期III reake研究的患者（EUR J CANC 81（2017）17-25
10. Extension of a Computer Assisted Decision Support (CADS) Study to Improve Outcomes in Patients with Type 2 DM Treated by Primary Care Providers. Addendum. [R] . Vigersky, R., Walker, S. 2015

机译：扩展计算机辅助决策支持（CaDs）研究，以改善初级保健提供者治疗的2型糖尿病患者的预后。附录。

Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study

摘要

著录项

相似文献

相关主题

期刊订阅